An official website of the United States government
Brain Disorders
Topics
- Acquired Cognitive Impairment
- Alzheimer's Disease
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Dementia
- Fetal Alcohol Spectrum Disorders (FASD)
- Transmissible Spongiform Encephalopathy (TSE)
- Frontotemporal Dementia (FTD)
- Multiple Sclerosis
- Anorexia
- Lewy Body Dementia
- Vascular Contributions to Cognitive Impairment & Dementia (VCID)
- Anxiety Disorders
- Aphasia
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Autism
- Batten Disease
- Bipolar Disorder
- Brain Cancer
- Cerebral Palsy
- Cerebrovascular Health
- Depression
- Down Syndrome
- Eating Disorders
- Epilepsy
- Fragile X
- Huntington's Disease
- Hydrocephalus
- Intellectual & Development Disabilities (IDD)
- Migraines
- Parkinson's Disease
- Post-Traumatic Stress Disorder (PTSD)
- Rett Syndrome
- Schizophrenia
- Stroke
- Tourette Syndrome
- Tuberous Sclerosis
Epilepsy Therapy Screening Program (ETSP)
Overview
The mission of the NINDS Epilepsy Therapy Screening Program (ETSP) is to facilitate the discovery of new therapeutic agents that address the unmet medical needs in epilepsy. Historically, the ETSP has focused on identifying symptomatic treatments for seizure disorders, but based on recent recommendations from working groups of the National Advisory Neurological Disorders and Stroke (NANDS) Council, the program is focused on identifying therapies that address drug resistant epilepsy, disease modification and prevention.
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD)
Accelerating Alzheimer's Research and Drug Development
The Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD) is a precompetitive partnership among government, industry, and nonprofit organizations to transform the current model for developing new diagnostics and treatments for Alzheimer's disease.
Accelerating Medicines Partnership (AMP)
Scientific Contacts for AMP AD
Laurie Ryan, Ph.D.
Email Laurie Ryan
Gabriella Miller Kids First Pediatric Research Program
Eunice Kennedy Shriver Intellectual & Developmental Disabilities Research Centers (EKS-IDDRCs)
Note: In fall 2024, NIH will publish a request for applications (RFA) for these centers. Please refer to NOT-HD-24-023 for important details about the upcoming RFA. The Frequently Asked Questions page also offers some additional information.
A Digitally Enhanced Model of Peer Doula Support for Substance Use Disorder and Peripartum Care (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®